J.N. Minatta

Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial

Karim Fizazi, Pablo González Mella, Daniel Castellano et al. · European Journal of Cancer · 2021 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Mihaela Aldea, Arianna Marinello, M. Duruisseaux et al. · Journal of Thoracic Oncology · 2023 · 48 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina

Claudio Martín, Lorena Lupinacci, Florencia Perazzo et al. · Clinical Lung Cancer · 2020 · 23 citations

Pharmacy, Oncology, Pharmacotherapy +8

Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort

Jordi Remón, Édouard Auclin, Leyre Zubiri et al. · ESMO Open · 2024 · 16 citations · Full text

Life Sciences, Immunology, Oncology +12

Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD

Karim Fizazi, Pablo González Mella, Daniel Castellano et al. · Annals of Oncology · 2019 · 14 citations · Full text

Medicine, Oncology, Pharmacology +14